STOCK TITAN

[S-8 POS] Streamline Health Solutions, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
S-8 POS
Rhea-AI Filing Summary

Streamline Health Solutions, Inc. filed post-effective amendments to multiple Form S-8 registration statements to deregister unsold securities after completing a merger. The company notes a 1-for-15 reverse stock split on October 4, 2024, was not reflected in the share totals shown in the historical registrations. On August 12, 2025, pursuant to a merger agreement, the company merged into a subsidiary of Mist Holding Co. and now survives as a wholly owned subsidiary, and as a result it has terminated all offerings under its existing Securities Act registrations. The amendments withdraw all unsold registered shares from the listed S-8 registrations, including the 6,738,902-share registration filed on June 24, 2024, and earlier registrations dating from 2013 through 2023.

Streamline Health Solutions, Inc. ha presentato emendamenti post‑effettivi a più dichiarazioni di registrazione sul Modulo S‑8 per cancellare i titoli non venduti dopo il completamento di una fusione. La società segnala che il frazionamento azionario inverso 1-per-15 del 4 ottobre 2024 non era riflesso nei totali delle azioni indicati nelle registrazioni storiche. In base a un accordo di fusione, il 12 agosto 2025 la società si è fusa in una controllata di Mist Holding Co. e ora sopravvive come controllata interamente partecipata; di conseguenza ha terminato tutte le offerte previste dalle sue registrazioni ai sensi del Securities Act. Gli emendamenti ritirano tutte le azioni registrate non vendute dalle registrazioni S‑8 elencate, inclusa la registrazione di 6.738.902 azioni depositata il 24 giugno 2024, oltre alle registrazioni precedenti dal 2013 al 2023.

Streamline Health Solutions, Inc. presentó enmiendas posteriores a la efectividad a varias declaraciones de registro en el Formulario S-8 para dar de baja los valores no vendidos tras completar una fusión. La compañía indica que la división inversa de acciones 1 por 15 del 4 de octubre de 2024 no se reflejó en los totales de acciones mostrados en los registros históricos. Con arreglo a un acuerdo de fusión, el 12 de agosto de 2025 la compañía se fusionó en una subsidiaria de Mist Holding Co. y ahora subsiste como subsidiaria de propiedad total; por consiguiente ha terminado todas las ofertas bajo sus registros conforme al Securities Act. Las enmiendas retiran todas las acciones registradas no vendidas de las registraciones S-8 listadas, incluida la registración de 6,738,902 acciones presentada el 24 de junio de 2024, así como las registraciones anteriores entre 2013 y 2023.

Streamline Health Solutions, Inc.는 합병 완료 후 미판매 증권을 말소하기 위해 다수의 Form S-8 등록명세서에 대한 사후 유효성 갱신 수정서를 제출했습니다. 회사는 2024년 10월 4일 시행된 1대15 비율의 액면병합(리버스 스톡 스플릿)이 과거 등록서류에 표시된 주식 총수에 반영되지 않았다고 밝혔습니다. 합병계약에 따라 2025년 8월 12일 회사는 Mist Holding Co.의 계열사로 합병되어 현재 완전 자회사로 존속하며, 이에 따라 Securities Act에 따른 기존 등록에 따른 모든 공모를 종료했습니다. 해당 수정서는 2024년 6월 24일 제출된 6,738,902주 등록을 포함하여 2013년부터 2023년까지의 이전 등록을 포함한 명시된 S-8 등록에서 미판매 등록주식을 모두 철회합니다.

Streamline Health Solutions, Inc. a déposé des amendements post‑efficacité à plusieurs déclarations d'enregistrement sur le formulaire S‑8 afin de radier les titres invendus après l'achèvement d'une fusion. La société indique que le regroupement d'actions par réduction 1 pour 15 en date du 4 octobre 2024 n'a pas été reflété dans les totaux d'actions figurant dans les enregistrements historiques. Conformément à un accord de fusion, le 12 août 2025 la société a été absorbée par une filiale de Mist Holding Co. et subsiste désormais en tant que filiale en propriété exclusive ; par conséquent, elle a mis fin à toutes les offres au titre de ses enregistrements en vertu du Securities Act. Les amendements retirent toutes les actions enregistrées invendues des enregistrements S‑8 énumérés, y compris l'enregistrement de 6 738 902 actions déposé le 24 juin 2024, ainsi que les enregistrements antérieurs de 2013 à 2023.

Streamline Health Solutions, Inc. hat nach Wirksamkeitserklärungen Nachträge zu mehreren Registrierungsformularen S‑8 eingereicht, um nach einer Fusion nicht verkaufte Wertpapiere zu löschen. Das Unternehmen weist darauf hin, dass die Aktienzusammenlegung im Verhältnis 1:15 vom 4. Oktober 2024 in den in den historischen Registrierungen ausgewiesenen Aktienzahlen nicht berücksichtigt wurde. Gemäß einer Fusionsvereinbarung ging die Gesellschaft am 12. August 2025 in eine Tochtergesellschaft von Mist Holding Co. auf und besteht nun als hundertprozentige Tochter; infolgedessen hat sie alle Angebote unter ihren bestehenden Securities Act-Registrierungen beendet. Die Nachträge ziehen alle nicht verkauften registrierten Aktien aus den aufgeführten S‑8-Registrierungen zurück, einschließlich der am 24. Juni 2024 eingereichten Registrierung über 6.738.902 Aktien sowie früherer Registrierungen aus den Jahren 2013 bis 2023.

Positive
  • Merger completed on August 12, 2025 making the company a wholly owned subsidiary of Mist Holding Co.
  • Registrant complied with its undertaking by filing post-effective amendments to withdraw unsold S-8 securities.
  • Large 2024 registration of 6,738,902 shares explicitly identified and addressed in the amendments.
Negative
  • Termination of offerings under existing Securities Act registrations reduces the pool of publicly registered shares available for issuance under prior S-8 plans.
  • Registration counts unadjusted for the 1-for-15 reverse stock split effected October 4, 2024, which may cause reconciliation steps for stakeholders.

Insights

TL;DR: The company completed a merger and, consistent with the agreement, deregistered its unsold employee-plan shares.

The filing confirms that on August 12, 2025 the registrant became a wholly owned subsidiary following a merger into MD BE Merger Sub, Inc., parented by Mist Holding Co. As a procedural consequence the registrant terminated its Securities Act offerings and executed post-effective amendments to remove unsold securities from multiple Form S-8 registrations. The filing also notes historic registration share counts were not adjusted for the 1-for-15 reverse split effected on October 4, 2024. This is a material corporate-structural event that changes Streamline Health's public reporting and equity registration status.

TL;DR: The company fulfilled its registration undertaking and formally withdrew unsold S-8 shares following change of control.

The registrant followed the undertaking in its S-8 filings to remove from registration any securities remaining unsold at termination of the offering by filing post-effective amendments. The amendments list multiple prior Form S-8 filings (2013–2024) and specify amounts reserved under various employee plans, including 6,738,902 shares from the 2024 filing. The disclosure is procedural and documents compliance with Securities Act obligations after the change in control.

Streamline Health Solutions, Inc. ha presentato emendamenti post‑effettivi a più dichiarazioni di registrazione sul Modulo S‑8 per cancellare i titoli non venduti dopo il completamento di una fusione. La società segnala che il frazionamento azionario inverso 1-per-15 del 4 ottobre 2024 non era riflesso nei totali delle azioni indicati nelle registrazioni storiche. In base a un accordo di fusione, il 12 agosto 2025 la società si è fusa in una controllata di Mist Holding Co. e ora sopravvive come controllata interamente partecipata; di conseguenza ha terminato tutte le offerte previste dalle sue registrazioni ai sensi del Securities Act. Gli emendamenti ritirano tutte le azioni registrate non vendute dalle registrazioni S‑8 elencate, inclusa la registrazione di 6.738.902 azioni depositata il 24 giugno 2024, oltre alle registrazioni precedenti dal 2013 al 2023.

Streamline Health Solutions, Inc. presentó enmiendas posteriores a la efectividad a varias declaraciones de registro en el Formulario S-8 para dar de baja los valores no vendidos tras completar una fusión. La compañía indica que la división inversa de acciones 1 por 15 del 4 de octubre de 2024 no se reflejó en los totales de acciones mostrados en los registros históricos. Con arreglo a un acuerdo de fusión, el 12 de agosto de 2025 la compañía se fusionó en una subsidiaria de Mist Holding Co. y ahora subsiste como subsidiaria de propiedad total; por consiguiente ha terminado todas las ofertas bajo sus registros conforme al Securities Act. Las enmiendas retiran todas las acciones registradas no vendidas de las registraciones S-8 listadas, incluida la registración de 6,738,902 acciones presentada el 24 de junio de 2024, así como las registraciones anteriores entre 2013 y 2023.

Streamline Health Solutions, Inc.는 합병 완료 후 미판매 증권을 말소하기 위해 다수의 Form S-8 등록명세서에 대한 사후 유효성 갱신 수정서를 제출했습니다. 회사는 2024년 10월 4일 시행된 1대15 비율의 액면병합(리버스 스톡 스플릿)이 과거 등록서류에 표시된 주식 총수에 반영되지 않았다고 밝혔습니다. 합병계약에 따라 2025년 8월 12일 회사는 Mist Holding Co.의 계열사로 합병되어 현재 완전 자회사로 존속하며, 이에 따라 Securities Act에 따른 기존 등록에 따른 모든 공모를 종료했습니다. 해당 수정서는 2024년 6월 24일 제출된 6,738,902주 등록을 포함하여 2013년부터 2023년까지의 이전 등록을 포함한 명시된 S-8 등록에서 미판매 등록주식을 모두 철회합니다.

Streamline Health Solutions, Inc. a déposé des amendements post‑efficacité à plusieurs déclarations d'enregistrement sur le formulaire S‑8 afin de radier les titres invendus après l'achèvement d'une fusion. La société indique que le regroupement d'actions par réduction 1 pour 15 en date du 4 octobre 2024 n'a pas été reflété dans les totaux d'actions figurant dans les enregistrements historiques. Conformément à un accord de fusion, le 12 août 2025 la société a été absorbée par une filiale de Mist Holding Co. et subsiste désormais en tant que filiale en propriété exclusive ; par conséquent, elle a mis fin à toutes les offres au titre de ses enregistrements en vertu du Securities Act. Les amendements retirent toutes les actions enregistrées invendues des enregistrements S‑8 énumérés, y compris l'enregistrement de 6 738 902 actions déposé le 24 juin 2024, ainsi que les enregistrements antérieurs de 2013 à 2023.

Streamline Health Solutions, Inc. hat nach Wirksamkeitserklärungen Nachträge zu mehreren Registrierungsformularen S‑8 eingereicht, um nach einer Fusion nicht verkaufte Wertpapiere zu löschen. Das Unternehmen weist darauf hin, dass die Aktienzusammenlegung im Verhältnis 1:15 vom 4. Oktober 2024 in den in den historischen Registrierungen ausgewiesenen Aktienzahlen nicht berücksichtigt wurde. Gemäß einer Fusionsvereinbarung ging die Gesellschaft am 12. August 2025 in eine Tochtergesellschaft von Mist Holding Co. auf und besteht nun als hundertprozentige Tochter; infolgedessen hat sie alle Angebote unter ihren bestehenden Securities Act-Registrierungen beendet. Die Nachträge ziehen alle nicht verkauften registrierten Aktien aus den aufgeführten S‑8-Registrierungen zurück, einschließlich der am 24. Juni 2024 eingereichten Registrierung über 6.738.902 Aktien sowie früherer Registrierungen aus den Jahren 2013 bis 2023.

As filed with the Securities and Exchange Commission on August 14, 2025

 

Registration No. 333-280444

Registration No. 333-188764

Registration No. 333-208752

Registration No. 333-220953

Registration No. 333-233728

Registration No. 333-258445

Registration No. 333-265774

Registration No. 333-272995

 



 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

Post-Effective Amendment No. 1 to Form S-8 Registration No. 333-280444

Post-Effective Amendment No. 1 to Form S-8 Registration No. 333-188764

Post-Effective Amendment No. 1 to Form S-8 Registration No. 333-208752

Post-Effective Amendment No. 1 to Form S-8 Registration No. 333-220953

Post-Effective Amendment No. 1 to Form S-8 Registration No. 333-233728

Post-Effective Amendment No. 1 to Form S-8 Registration No. 333-258445

Post-Effective Amendment No. 1 to Form S-8 Registration No. 333-265774

Post-Effective Amendment No. 1 to Form S-8 Registration No. 333-272995

 

UNDER

THE SECURITIES ACT OF 1933

 


 

STREAMLINE HEALTH SOLUTIONS, INC.

(Exact Name of Registrant as Specified in its Charter)

 


 

Delaware

 

0-28132

 

31-1455414

(State or Other Jurisdiction of

Incorporation or Organization)

 

(Commission File Number)

 

(I.R.S. Employer

Identification No.)

         

2400 Old Milton Pkwy., Box 1353

Alpharetta, GA 30009

(203) 883-9490

(Address of Principal Executive Offices) (Zip Code)

 

Streamline Health Solutions, Inc. 2025 Omnibus Incentive Compensation Plan
Streamline Health Solutions, Inc. Third Amended and Restated 2013 Stock Incentive Plan

(Full title of the plans)

 

 

Bryant J. Reeves, III

 

Chief Financial Officer

2400 Old Milton Pkwy., Box 1353

Alpharetta, Georgia 30009

(888) 997-8732

 

(Name and address of agent for service) (Telephone number, including area code, of agent for service)

 

 

 

 

Copies to:

David W. Ghegan

Cody M. Mathis

Troutman Pepper Locke LLP

600 Peachtree Street NE, Suite 3000

Atlanta, Georgia 30308

(404) 885-3139

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

               

Large accelerated filer

 

 

Accelerated filer

     
         

Non-accelerated filer

 

x

 

Smaller reporting company

 

x

 
         
       

Emerging growth company

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

 



 

 


 

 

 

EXPLANATORY NOTE DEREGISTRATION OF SECURITIES

 

These Post-Effective Amendments (these “Post-Effective Amendments”) relate to the following Registration Statements on Form S-8 (each, a “Registration Statement,” and collectively, the “Registration Statements”), filed with the Securities and Exchange Commission (the “SEC”) by Streamline Health Solutions, Inc., a Delaware corporation (the “Registrant”):

 

 

Registration Statement on Form S-8 (No. 333‑188764), filed with the SEC on May 22, 2013, pertaining to the registration of 2,000,000 shares of common stock, par value $0.01 per share (“Common Stock”) of the Registrant reserved for issuance under the Streamline Health Solutions, Inc. Third Amended and Restated 2013 Stock Incentive Plan (the “2013 Plan”);

 

 

Registration Statement on Form S-8 (No. 333‑208752), filed with the SEC on December 24, 2015, pertaining to the registration of (i) an additional 1,600,000 shares of Common Stock of the Registrant reserved for issuance under the 2013 Plan and (ii) 300,000 shares of Common Stock issuable upon the exercise of new employee inducement stock option awards;

 

 

Registration Statement on Form S-8 (No. 333‑220953), filed with the SEC on October 13, 2017, pertaining to the registration of (i) an additional 300,000 shares of Common Stock of the Registrant reserved for issuance under the 2013 Plan and (ii) 75,000 shares of Common Stock issuable upon the exercise of a new employee inducement stock option award;

 

 

Registration Statement on Form S-8 (No. 333‑233728), filed with the SEC on September 12, 2019, pertaining to the registration of (i) an additional 1,000,000 shares of Common Stock of the Registrant reserved for issuance under the 2013 Plan and (ii) 225,000 shares of Common Stock issuable under new-employee inducement restricted stock awards;

 

 

Registration Statement on Form S-8 (No. 333‑258445), filed with the SEC on August 4, 2021, pertaining to the registration of an additional 2,000,000 shares of Common Stock of the Registrant reserved for issuance under the 2013 Plan;

 

 

Registration Statement on Form S-8 (No. 333‑265774), filed with the SEC on June 22, 2022, pertaining to the registration of an additional 2,000,000 shares of Common Stock of the Registrant reserved for issuance under the 2013 Plan;

 

 

Registration Statement on Form S-8 (No. 333‑272995), filed with the SEC on June 28, 2023, pertaining to the registration of an additional 1,000,000 shares of Common Stock of the Registrant reserved for issuance under the 2013 Plan; and

 

 

Registration Statement on Form S-8 (No. 333‑280444), filed with the SEC on June 24, 2024, pertaining to the registration of 6,738,902 shares of Common Stock of the Registrant, which consists of (i) 6,000,000 shares of Common Stock reserved for issuance under the Streamline Health Solutions, Inc. 2024 Omnibus Incentive Compensation Plan (the “2024 Plan”) and (ii) 738,902 shares of Common Stock available for issuance (or which may become available for issuance) under the 2013 Plan.

 

The number of shares of Common Stock registered under the Registration Statements set forth above have not been adjusted to reflect the 1-for-15 reverse stock split of the issued and outstanding shares of Common Stock effected by the Company on October 4, 2024.

 

On August 12, 2025, pursuant to the terms of the Agreement and Plan of Merger, dated May 29, 2025, by and among the Registrant, Mist Holding Co., a Delaware corporation and the parent company of Hayes Management Consulting LLC d/b/a MDaudit (“Parent”), and MD BE Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”), Merger Sub merged with and into the Registrant (the “Merger”), with the Registrant surviving the Merger as a wholly owned subsidiary of Parent.

 

As a result of the Merger, the Registrant has terminated, as of the date hereof, all offerings of its securities pursuant to its existing registration statements under the Securities Act of 1933, as amended (the “Securities Act”), including the Registration Statements. In accordance with an undertaking made by the Registrant in the Registration Statements to remove from registration by means of a post-effective amendment any of the securities which remain unsold at the termination of the offering, Registrant hereby removes and withdraws from registration all securities of the Registrant registered pursuant to the Registration Statements that remain unsold as of the date hereof, and the Registration Statements are hereby amended, as appropriate, to reflect the deregistration of such securities. 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused these Post-Effective Amendments to the Registration Statements on Form S-8 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Atlanta, State of Georgia, on August 14, 2025. No other person is required to sign these Post-Effective Amendments to the Registration Statements on Form S-8 in reliance on Rule 478 of the Securities Act

 

STREAMLINE HEALTH SOLUTIONS, INC.

 

 

By: /s/ Nick Barnes                                             

Nick Barnes

Chief Financial Officer, Treasurer and Secretary 

 

 


 

 

FAQ

What happened to Streamline Health's (STRM) Form S-8 registrations?

The company filed post-effective amendments to withdraw all unsold securities from its listed Form S-8 registration statements, thereby deregistering those shares.

When did the merger that triggered the deregistration occur?

The Merger was completed on August 12, 2025, after which Streamline Health became a wholly owned subsidiary of Mist Holding Co.

Which large S-8 registration is specifically referenced in the filing?

The filing specifically references the June 24, 2024 Form S-8 registering 6,738,902 shares (6,000,000 for the 2024 Plan and 738,902 related to the 2013 Plan).

Was there a reverse stock split and is it reflected in the S-8 totals?

Yes, a 1-for-15 reverse stock split was effected on October 4, 2024, and the filing states the registration numbers have not been adjusted to reflect that split.

Does the filing indicate the company will continue public offerings?

No; the filing states the company has terminated all offerings under its existing Securities Act registrations and removed unsold registered securities as of the date of the filing.

Which employee plans were affected by these S-8 deregisrations?

The affected plans include the Streamline Health Solutions, Inc. 2024 Omnibus Incentive Compensation Plan and the Third Amended and Restated 2013 Stock Incentive Plan, as referenced in the filing.
Streamline Health Solutions In

NASDAQ:STRM

STRM Rankings

STRM Latest News

STRM Latest SEC Filings

STRM Stock Data

23.23M
3.60M
17.45%
26.05%
0.51%
Health Information Services
Services-computer Integrated Systems Design
Link
United States
ALPHARETTA